Cargando…
Diagnostic value of anti‐citrullinated α‐enolase peptide 1 antibody in patients with rheumatoid arthritis: A systematic review and meta‐analysis
AIM: To evaluate the diagnostic value of anti‐citrullinated α‐enolase peptide 1 (anti‐CEP 1) antibody in patients with rheumatoid arthritis (RA) by conducting a systematic review and meta‐analysis. METHODS: The PubMed, Web of Science, Embase, Scopus, and Cochrane Library databases were searched for...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252446/ https://www.ncbi.nlm.nih.gov/pubmed/33713557 http://dx.doi.org/10.1111/1756-185X.14093 |
_version_ | 1783717302161637376 |
---|---|
author | Li, Haolong Li, Liubing Liu, Chenxi Cheng, Linlin Yan, Songxin Chen, Haizhen Li, Yongzhe |
author_facet | Li, Haolong Li, Liubing Liu, Chenxi Cheng, Linlin Yan, Songxin Chen, Haizhen Li, Yongzhe |
author_sort | Li, Haolong |
collection | PubMed |
description | AIM: To evaluate the diagnostic value of anti‐citrullinated α‐enolase peptide 1 (anti‐CEP 1) antibody in patients with rheumatoid arthritis (RA) by conducting a systematic review and meta‐analysis. METHODS: The PubMed, Web of Science, Embase, Scopus, and Cochrane Library databases were searched for relevant studies published until September 23, 2020. A bivariate mixed‐effects model was used to calculate the diagnostic indices from primary data of eligible studies. We performed meta‐regression and subgroup analysis to explore the sources of heterogeneity. RESULTS: Twenty‐four articles, with a total of 17 380 patients with RA and 7505 control participants, met the criteria for inclusion in the meta‐analysis. The pooled sensitivity, specificity, and positive and negative likelihood ratios for the anti‐CEP 1 antibody were 44% (95% CI: 38%‐51%), 97% (95% CI: 96%‐98%), and 14.81 (95% CI: 10.66‐20.57) and 0.57 (95% CI: 0.52‐0.64), respectively. The pooled positive and negative predictive values were 0.96 (95% CI: 0.95‐0.97) and 0.53 (95% CI: 0.43‐0.63), respectively. The area under the summary receiver operating characteristic curve was 0.86. Meta‐regression indicated that the anti‐CEP 1 antibody detection method may be a source of heterogeneity. The subgroup analysis of the group in which the anti‐CEP 1 antibody was detected by using a commercial enzyme‐linked immunosorbent assay (ELISA) kit had a sensitivity of 59% (95% CI: 50%‐68%) and a specificity of 93% (95% CI: 85%‐97%). CONCLUSIONS: The anti‐CEP 1 antibody had moderate RA diagnostic value with relatively low sensitivity and high specificity. An ELISA may increase the RA diagnostic sensitivity. |
format | Online Article Text |
id | pubmed-8252446 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-82524462021-07-07 Diagnostic value of anti‐citrullinated α‐enolase peptide 1 antibody in patients with rheumatoid arthritis: A systematic review and meta‐analysis Li, Haolong Li, Liubing Liu, Chenxi Cheng, Linlin Yan, Songxin Chen, Haizhen Li, Yongzhe Int J Rheum Dis Review Articles AIM: To evaluate the diagnostic value of anti‐citrullinated α‐enolase peptide 1 (anti‐CEP 1) antibody in patients with rheumatoid arthritis (RA) by conducting a systematic review and meta‐analysis. METHODS: The PubMed, Web of Science, Embase, Scopus, and Cochrane Library databases were searched for relevant studies published until September 23, 2020. A bivariate mixed‐effects model was used to calculate the diagnostic indices from primary data of eligible studies. We performed meta‐regression and subgroup analysis to explore the sources of heterogeneity. RESULTS: Twenty‐four articles, with a total of 17 380 patients with RA and 7505 control participants, met the criteria for inclusion in the meta‐analysis. The pooled sensitivity, specificity, and positive and negative likelihood ratios for the anti‐CEP 1 antibody were 44% (95% CI: 38%‐51%), 97% (95% CI: 96%‐98%), and 14.81 (95% CI: 10.66‐20.57) and 0.57 (95% CI: 0.52‐0.64), respectively. The pooled positive and negative predictive values were 0.96 (95% CI: 0.95‐0.97) and 0.53 (95% CI: 0.43‐0.63), respectively. The area under the summary receiver operating characteristic curve was 0.86. Meta‐regression indicated that the anti‐CEP 1 antibody detection method may be a source of heterogeneity. The subgroup analysis of the group in which the anti‐CEP 1 antibody was detected by using a commercial enzyme‐linked immunosorbent assay (ELISA) kit had a sensitivity of 59% (95% CI: 50%‐68%) and a specificity of 93% (95% CI: 85%‐97%). CONCLUSIONS: The anti‐CEP 1 antibody had moderate RA diagnostic value with relatively low sensitivity and high specificity. An ELISA may increase the RA diagnostic sensitivity. John Wiley and Sons Inc. 2021-03-13 2021-05 /pmc/articles/PMC8252446/ /pubmed/33713557 http://dx.doi.org/10.1111/1756-185X.14093 Text en © 2021 The Authors. International Journal of Rheumatic Diseases published by Asia Pacific League of Associations for Rheumatology and John Wiley & Sons Australia, Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Review Articles Li, Haolong Li, Liubing Liu, Chenxi Cheng, Linlin Yan, Songxin Chen, Haizhen Li, Yongzhe Diagnostic value of anti‐citrullinated α‐enolase peptide 1 antibody in patients with rheumatoid arthritis: A systematic review and meta‐analysis |
title | Diagnostic value of anti‐citrullinated α‐enolase peptide 1 antibody in patients with rheumatoid arthritis: A systematic review and meta‐analysis |
title_full | Diagnostic value of anti‐citrullinated α‐enolase peptide 1 antibody in patients with rheumatoid arthritis: A systematic review and meta‐analysis |
title_fullStr | Diagnostic value of anti‐citrullinated α‐enolase peptide 1 antibody in patients with rheumatoid arthritis: A systematic review and meta‐analysis |
title_full_unstemmed | Diagnostic value of anti‐citrullinated α‐enolase peptide 1 antibody in patients with rheumatoid arthritis: A systematic review and meta‐analysis |
title_short | Diagnostic value of anti‐citrullinated α‐enolase peptide 1 antibody in patients with rheumatoid arthritis: A systematic review and meta‐analysis |
title_sort | diagnostic value of anti‐citrullinated α‐enolase peptide 1 antibody in patients with rheumatoid arthritis: a systematic review and meta‐analysis |
topic | Review Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252446/ https://www.ncbi.nlm.nih.gov/pubmed/33713557 http://dx.doi.org/10.1111/1756-185X.14093 |
work_keys_str_mv | AT lihaolong diagnosticvalueofanticitrullinatedaenolasepeptide1antibodyinpatientswithrheumatoidarthritisasystematicreviewandmetaanalysis AT liliubing diagnosticvalueofanticitrullinatedaenolasepeptide1antibodyinpatientswithrheumatoidarthritisasystematicreviewandmetaanalysis AT liuchenxi diagnosticvalueofanticitrullinatedaenolasepeptide1antibodyinpatientswithrheumatoidarthritisasystematicreviewandmetaanalysis AT chenglinlin diagnosticvalueofanticitrullinatedaenolasepeptide1antibodyinpatientswithrheumatoidarthritisasystematicreviewandmetaanalysis AT yansongxin diagnosticvalueofanticitrullinatedaenolasepeptide1antibodyinpatientswithrheumatoidarthritisasystematicreviewandmetaanalysis AT chenhaizhen diagnosticvalueofanticitrullinatedaenolasepeptide1antibodyinpatientswithrheumatoidarthritisasystematicreviewandmetaanalysis AT liyongzhe diagnosticvalueofanticitrullinatedaenolasepeptide1antibodyinpatientswithrheumatoidarthritisasystematicreviewandmetaanalysis |